Targeting sleep physiology to modulate glymphatic brain clearance

T van Hattem, L Verkaar, E Krugliakova… - …, 2024 - journals.physiology.org
Sleep has been postulated to play an important role in the removal of potentially neurotoxic
molecules, such as amyloid-β, from the brain via the glymphatic system. Disturbed sleep, on …

Exploring the dynamics of snoring in relation to sleep stages: Implications for gender differences, sleep position, and upper airway collapsibility

M Suzuki, Y Kawai, Y Funayama - Plos one, 2024 - journals.plos.org
Objective The purpose of this study was to determine the sleep stage during which isolated
snoring occurs in children and adults, and to analyze changes after treatment of obstructive …

Arousal burden is highest in supine sleeping position and during light sleep

M Pitkänen, J Huovinen, M Rissanen… - Journal of Clinical …, 2024 - jcsm.aasm.org
Study Objectives: Arousal burden (AB) is defined as the cumulative duration of arousals
during sleep divided by the total sleep time. However, in-depth analysis of AB related to …

Effects of high dietary carbohydrate intake in patients with obstructive sleep apnea

Y Shi, J Xu, S Yi, C Xu, F Yu, W Gu, J Zhang, L Ye - Sleep and Breathing, 2025 - Springer
Background This study aimed to characterize the relationship between habitual food intake
and OSA. Methods The diet of 200 volunteers was evaluated using a Food Frequency …

Consensus Statements among European Sleep Surgery Experts on Snoring and Obstructive Sleep Apnea: Part 2 Decision-Making in Surgical Management and Peri …

E Olszewska, A De Vito, C O'Connor-Reina… - Journal of Clinical …, 2024 - mdpi.com
Background: Reaching consensus on decision-making in surgical management and peri-
operative considerations regarding snoring and obstructive sleep apnea (OSA) among …

Phrenic nerve stimulation for central sleep apnea: a single institution experience

J Mease, R Augostini, S McKane, M Khan - Sleep and Breathing, 2024 - Springer
Purpose Phrenic nerve stimulation (PNS) was approved by the Food and Drug
Administration (FDA) to treat moderate to severe central sleep apnea. We report here …